sglt 2 for pets
Released dec 11 2018.
A proof of concept study has begun to evaluate the glucosuria effect of TFC-039. This will address the simple question of whether the molecule engages with the feline receptor in a manner that would make TFC-039 a suitable drug development candidate. Results for this initial study are expected later this month.
Two years later:
We expect an update on this project soon, however, we caution that due to holidays, we cannot be certain that news will be released prior to year-end.